# Yoram Bouhnik

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yoram-bouhnik/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,339 |
| Field | Inflammatory Bowel Disease |
| h-index | 91 |
| i10-index | 244 |
| Last Known Institution | Clinique Ambroise Paré |
| OpenAlex ID | https://openalex.org/A5070441072 |
| ORCID iD | 0000-0002-5787-4943 |
| Works | 574 |

## Researcher papers

Showing 12 of 17.

- [Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study](https://scholariq.org/papers/lymphoproliferative-disorders-in-patients-receiving-thiopurines-for-inflammatory/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines](https://scholariq.org/papers/imaging-techniques-for-assessment-of-inflammatory-bowel-disease-joint-ecco-and/)
- [Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial](https://scholariq.org/papers/ciclosporin-versus-infliximab-in-patients-with-severe-ulcerative-colitis/)
- [Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped](https://scholariq.org/papers/maintenance-of-remission-among-patients-with-crohn-s-disease-on-antimetabolite/)
- [Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine](https://scholariq.org/papers/long-term-follow-up-of-patients-with-crohn-s-disease-treated-with-azathioprine/)
- [Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy](https://scholariq.org/papers/resistance-of-t-11-18-positive-gastric-mucosa-associated-lymphoid-tissue/)
- [Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial](https://scholariq.org/papers/ineffectiveness-of-i-lactobacillus-johnsonii-i-la1-for-prophylaxis-of/)
- [Abnormal intestinal intraepithelial lymphocytes in refractory sprue](https://scholariq.org/papers/abnormal-intestinal-intraepithelial-lymphocytes-in-refractory-sprue/)
- [The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study](https://scholariq.org/papers/the-capacity-of-nondigestible-carbohydrates-to-stimulate-fecal-bifidobacteria-in/)
- [Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II](https://scholariq.org/papers/presentation-and-long-term-follow-up-of-refractory-celiac-disease-comparison-of/)
- [Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED–ECCO consensus](https://scholariq.org/papers/role-of-small-bowel-endoscopy-in-the-management-of-patients-with-inflammatory/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Diverticular Disease and Complications](https://scholariq.org/topics/diverticular-disease-and-complications/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Researcher university

- [Clinique Ambroise Paré](https://scholariq.org/institutions/clinique-ambroise-pare/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.